Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Aug 4, 2026
- Incorporated
- Massachusetts
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 875320
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 52
Prospectuses and Registrations 8 of 11
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 13, 2026
- S-8 Registration statement for an employee plan May 13, 2026
Proxies 8 of 16
- DEFA14A Extra proxy material Apr 29, 2026
- DEFA14A Extra proxy material Apr 2, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 2, 2026
- DEFA14A Extra proxy material Apr 3, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2025
- PX14A6G Shareholder's own proxy material Apr 16, 2024
- DEFA14A Extra proxy material Apr 4, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2024
Ownership 8 of 877
- 4 Insider reported a trade Jul 23, 2026
- 4 Insider reported a trade Jul 23, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 6, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
Other 8 of 20
- UPLOAD Comment letter from SEC staff Apr 14, 2026
- ARS Annual report sent to shareholders Apr 2, 2026
- CORRESP Reply to SEC staff Apr 1, 2026
- UPLOAD Comment letter from SEC staff Mar 18, 2026
- UPLOAD Comment letter from SEC staff May 7, 2025
- CORRESP Reply to SEC staff May 5, 2025
- UPLOAD Comment letter from SEC staff Apr 7, 2025
- ARS Annual report sent to shareholders Apr 3, 2025
Everything here comes from Vertex Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.